Cargando…
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709721/ https://www.ncbi.nlm.nih.gov/pubmed/34941995 http://dx.doi.org/10.1182/bloodadvances.2021006112 |
| _version_ | 1784623004100067328 |
|---|---|
| author | Dahiya, Saurabh Luetkens, Tim Lutfi, Forat Avila, Stephanie Iraguha, Thierry Margiotta, Philip Hankey, Kim G. Lesho, Patricia Law, Jennie Y. Lee, Seung T. Baddley, John Kocoglu, Mehmet Yared, Jean A. Hardy, Nancy M. Rapoport, Aaron P. Atanackovic, Djordje |
| author_facet | Dahiya, Saurabh Luetkens, Tim Lutfi, Forat Avila, Stephanie Iraguha, Thierry Margiotta, Philip Hankey, Kim G. Lesho, Patricia Law, Jennie Y. Lee, Seung T. Baddley, John Kocoglu, Mehmet Yared, Jean A. Hardy, Nancy M. Rapoport, Aaron P. Atanackovic, Djordje |
| author_sort | Dahiya, Saurabh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8709721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87097212021-12-28 Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy Dahiya, Saurabh Luetkens, Tim Lutfi, Forat Avila, Stephanie Iraguha, Thierry Margiotta, Philip Hankey, Kim G. Lesho, Patricia Law, Jennie Y. Lee, Seung T. Baddley, John Kocoglu, Mehmet Yared, Jean A. Hardy, Nancy M. Rapoport, Aaron P. Atanackovic, Djordje Blood Adv Research Letter American Society of Hematology 2022-01-24 /pmc/articles/PMC8709721/ /pubmed/34941995 http://dx.doi.org/10.1182/bloodadvances.2021006112 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Dahiya, Saurabh Luetkens, Tim Lutfi, Forat Avila, Stephanie Iraguha, Thierry Margiotta, Philip Hankey, Kim G. Lesho, Patricia Law, Jennie Y. Lee, Seung T. Baddley, John Kocoglu, Mehmet Yared, Jean A. Hardy, Nancy M. Rapoport, Aaron P. Atanackovic, Djordje Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy |
| title | Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy |
| title_full | Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy |
| title_fullStr | Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy |
| title_full_unstemmed | Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy |
| title_short | Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy |
| title_sort | impaired immune response to covid-19 vaccination in patients with b-cell malignancies after cd19 car t-cell therapy |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709721/ https://www.ncbi.nlm.nih.gov/pubmed/34941995 http://dx.doi.org/10.1182/bloodadvances.2021006112 |
| work_keys_str_mv | AT dahiyasaurabh impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT luetkenstim impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT lutfiforat impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT avilastephanie impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT iraguhathierry impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT margiottaphilip impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT hankeykimg impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT leshopatricia impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT lawjenniey impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT leeseungt impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT baddleyjohn impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT kocoglumehmet impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT yaredjeana impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT hardynancym impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT rapoportaaronp impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy AT atanackovicdjordje impairedimmuneresponsetocovid19vaccinationinpatientswithbcellmalignanciesaftercd19cartcelltherapy |